AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT03440476 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Feedback-plus-personal-contact booster
Description: Booster emails will contain normative feedback indicating average consumption for students at the same institution by sex, their perceptions of student drinkers at the same institution, their own reported consumption, and reminders of strategies they can use to protect themselves from alcohol-related harm. The email is sent from an individual on the research staff.
Study NCT01614470 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ivacaftor
Description: 150 mg tablet, oral use, administered twice a day (q12h)
Study NCT01614470 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: oral use, administered twice a day (q12h)
Study NCT03874442 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: CliniPup serious game
Description: The interactive game is played at home by the children on a computer or tablet before the surgery. The SERES Pain in Children-game is created with realistic scenarios based on scientific literature about perioperative pain and fear in children. The primary goal of the game is to provide the children insight in the impact of their personal choices on their well-being and on their environment by giving the children information about the day of the surgery. The ultimate aim of the game is to create a change in behaviour, enhance children's coping strategies and reduce the burden of pain and fear in the children and parents.
Study NCT03456466 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TQB2303
Description: 375mg/m2 ，iv
Study NCT03456466 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Rituximab
Description: 375mg/m2 ，iv
Study NCT02890316 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Homeopathy remedy
Description: Homeopathy remedy, prescribed by a physician and prepared by licensed pharmacy.
Study NCT02890316 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Radiation as adjuvant therapy for breast cancer
Description: Daily radiation therapy.
Study NCT02890316 — intervention group
Intervention type: RADIATION
Group type: PLACEBO_COMPARATOR
Intervention: Radiation as adjuvant therapy for breast cancer
Description: Daily radiation therapy.
Study NCT04195711 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: objective pediatric vision screen, blinq,
Description: hand-held birefringent screener for simultaneous foveation
Study NCT03447548 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Neurofeedback processing speed training
Description: Processing speed training on tablets that incorporates changes in pupil size to titrate the learning algorithm
Study NCT03447548 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Active control
Description: Commercially available games on tablet
Study NCT01832337 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Limb remote ischemic preconditioning (LRIP)
Description: Limb remote ischemic preconditioning (LRIP) consisted of three cycles of left upper limb ischemia induced by inflating a blood pressure cuff on the left upper arm to 200mmHg, with an intervening 5 minutes of reperfusion, during which time the cuff was deflated.
Study NCT00004547 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Surgery
Description: Patients will undergo cytoreductive surgery to remove as much tumor as possible. Part of the intestines, pancreas, stomach or the entire spleen may also be removed if they are affected.
Study NCT00004547 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Continuous hyperthermic peritoneal perfusion (CHPP) with Cisplatin
Study NCT00004547 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Postoperative dwell with paclitaxel and 5-FU
Description: Intraperitoneal dwell chemotherapy with a combination of 5-FU and Paclitaxel will be delivered in the early postoperative period (day 7 today 12 after surgery). Patients will be premedicated with hydrocortisone (100 mg/intravenous push (i.v.p.)), diphenhydramine (50 mg i.v.p.) and ranitidine (50 mg i.v.p.) 30 minutes prior to delivering intraperitoneal chemotherapy. One liter of normal saline will be infused containing 5-FU (800 mg/M\^2) and 1 L of normal saline containing paclitaxel (125 mg/M\^2) will be infused over 60 minutes. The chemotherapy solution will be left in the abdominal cavity permanently for slow absorption.
Study NCT04044105 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pamphlet education
Description: Patients receive an educational intervention explaining proper opioid disposal
Study NCT04044105 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pamphlet education + texts
Description: Patients receive an educational intervention and text message explaining proper opioid disposal
Study NCT02992119 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: RTS,S/AS01B Fractional dose
Description: RTS,S/AS01B standard dose at Month 0 and Month 1 + RTS,S/AS01B fractional dose (1/5th dose) at Month 2.
Study NCT02992119 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Double RTS,S/AS01E Fractional dose
Description: A double dose of RTS,S/AS01E standard dose at Month 0 and Month 1 + a double dose of RTS,S/AS01E fractional dose (1/5th dose) at Month 2.
Study NCT02992119 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: RTS,S/AS01E Standard dose
Description: RTS,S/AS01E standard dose at Month 0, Month 1 and Month 2.
Study NCT02992119 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: RTS,S/AS01E + DHA-PIP+PQ Standard dose
Description: RTS,S/AS01E standard dose + DHA-PIP+PQ at Month 0, Month 1 and Month 2
Study NCT02992119 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: RTS,S/AS01E Fractional dose
Description: RTS,S/AS01E standard dose at Month 0 and Month 1 + RTS,S/AS01E fractional dose (1/5th dose) at Month 2.
Study NCT02992119 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: RTS,S/AS01E + DHA-PIP+PQ Fractional dose
Description: RTS,S/AS01E standard dose + DHA-PIP+PQ at Month 0 and Month 1 + RTS,S/AS01E fractional dose (1/5th dose) + DHA-PIP+PQ at Month 2.
Study NCT02992119 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: RTS,S/AS01E + DHA-PIP+PQ Fractional two-dose
Description: RTS,S/AS01E standard dose + DHA-PIP+PQ at Month 0 + RTS,S/AS01E fractional dose (1/5th dose) + DHA-PIP+PQ at Month 2
Study NCT02576392 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Intervention
Description: Intervention consisted of a mailing 2 weeks prior to surgery, another 2 weeks post surgery, and a pharmacist intervention if a refill of opioid medication was requested within 90 days of surgery.
Study NCT02361775 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Paravertebral catheter
Description: A catheter is placed ultrasound guided at the T5 paravertebral level
Study NCT02361775 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: opioid iv pca
Description: opioid pca consisting of hydromorphone
Study NCT02361775 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ropivacaine
Description: 0.2% ropivacaine infused through paravertebral catheter
Study NCT02361775 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Elastomeric Pump
Description: Elastomeric pump connected to paravertebral catheter
Study NCT03435588 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: EUS
Description: Radial endoscopic ultrasound. A special endoscope uses high-frequency sound waves to produce detailed images of the lining and walls of the digestive tract , and allows to take samples from abnormal areas.
Study NCT03435588 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: EUS
Description: Radial endoscopic ultrasound. A special endoscope uses high-frequency sound waves to produce detailed images of the lining and walls of the digestive tract , and allows to take samples from abnormal areas.
Study NCT03435588 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: FNA with ROSE
Description: Endoscopic ultrasound guided biopsy of the pancreas with the traditional fine needle aspirate needle with the addition of rapid on-site cytopathology (cytopathologist looking at each biopsy samples as they are taken): The sampling is done with a small needle called fine needle aspiration needle or FNA. FNA alone is sometimes limited due to inadequate acquisition of cells for proper diagnosis under the microscope, which can lead to need for repeat endoscopic procedures and delay in diagnosis and possibly treatment. Rapid on-site evaluation of cytopathology (ROSE) is where a cytopathologist is next to the physician doing the endoscopic procedures and evaluates each sampling performed.
Study NCT03435588 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: FNB alone
Description: Endoscopic ultrasound guided biopsy with a novel core biopsy needle without on-site cytopathology: New needles called core needles (fine needle biopsy, FNB) have recently been developed which not only acquires cells but also the entire tissue structure (histology).
Study NCT02456194 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Calcium Sulfate + Antibiotics + Internal Fixation
Description: STIMULAN Rapid Cure, mixed with antibiotic, and prepared in bead form. Must be used in conjunction with internal fixation. Choice of antibiotic is left to the surgeon's discretion.
Study NCT03563573 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Potassium Gluconate Oral Capsule
Description: Each subject will receive a dose of \~8 mg/kg of potassium. We will be giving a maximum of 14 mEq in a single dose.
Study NCT03563573 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo oral capsule
Description: Each subject will receive a dose of \~8 mg/kg of a placebo capsule
Study NCT04030741 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Meronem and flagyl
Description: meronem and flagy
Study NCT04030741 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Appendectomy
Description: Appendectomy as treatment for acute appendicitis
Study NCT02569892 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Pascal Retinal Laser Photocoagulator
Description: Sub-threshold macular laser treatment with Pascal laser Endpoint Management System
Study NCT02569892 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Pascal Retinal Laser Photocoagulator
Description: Sub-threshold macular laser treatment with Pascal laser Endpoint Management System
Study NCT04460326 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Insulin glargine
Description: Insulin glargine doses will be determined by calculating the total daily dose (TDD) of insulin and providing 50% of the TDD as follows: start at 0.5 units/kg/day and subtract 0.1 unit/kg/day for 70+ yrs of age, renal insufficiency, pancreatic deficiency and add 0.1 unit/kg/day if hemoglobin A1c in >10%
Study NCT04460326 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Insulin glargine
Description: Insulin glargine doses will be determined by calculating the total daily dose (TDD) of insulin and providing 50% of the TDD as follows: start at 0.5 units/kg/day and subtract 0.1 unit/kg/day for 70+ yrs of age, renal insufficiency, pancreatic deficiency and add 0.1 unit/kg/day if hemoglobin A1c in >10%
Study NCT04460326 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: NovoLog
Description: Novolog will be administered with each meal if premeal glucose is ≥ 150 mg/dL and at bedtime if glucose is ≥ 200 mg/dL by calculating an individualized insulin sensitivity factor for each subject per the following formula: 1500/total daily dose of insulin = sensitivity factor.
Study NCT04460326 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Insulin Fiasp
Description: Fiasp will be administered with each meal if premeal glucose is ≥ 150 mg/dL and at bedtime if glucose is ≥ 200 mg/dL by calculating an individualized insulin sensitivity factor for each subject per the following formula: 1500/total daily dose of insulin = sensitivity factor.
Study NCT04460326 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard carbohydrate diet
Description: Standard carbohydrate diet as per usual hospital care (75g with each meal)
Study NCT04460326 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Standard carbohydrate diet
Description: Standard carbohydrate diet as per usual hospital care (75g with each meal)
Study NCT04554589 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Glycopyrrolate 0.2 MG
Description: injections
Study NCT04554589 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: normal saline
Description: normal saline
Study NCT02295072 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: A 5-months physical exercise-based program
Description: The physical exercise program consists of 3-5 after-school sessions/week of 90 min plus exercise homework in the weekends, and will focus on high-intensity aerobic exercise mainly.
Study NCT01499810 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Bilateral radiofrequency sympathetic renal denervation
Description: Bilateral radiofrequency sympathetic renal denervation is performed as percutaneous transluminal radiofrequency (RF) ablation of neural pathways in the renal artery walls and surrounding tissue using standard equipment for RF ablation of cardiac electrical pathways
Study NCT04020211 — intervention group
Intervention type: DEVICE
Intervention: Senza HF10 Therapy
Description: Senza 10kHz Spinal Cord Stimulation
Study NCT02171546 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dabigatran etexilate capsules
Study NCT02171546 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dabigatran etexilate capsules
Study NCT02171546 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Quinidine sulfate tablets
Study NCT02171546 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fexofenadine tablets
Study NCT02171546 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Fexofenadine tablets
Study NCT02084511 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo to BI 1026706 solution
Description: Placebo to BI 1026706 solution
Study NCT02084511 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BI 1026706
Description: BI 1026706
Study NCT02084511 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo to BI 1026706 tablet
Description: Placebo to BI 1026706 tablet
Study NCT02084511 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Celecoxib
Description: Celecoxib capsule
Study NCT01555658 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bivalirudin
Description: Enrolled patients will be randomized 1:1 in the catheterization laboratory, after the decision to perform PCI by means of planned implantation of stents>33 mm in length in the same coronary vessel, to IV bivalirudin (0.75 mg/kg intravenous bolus followed by 1.75 mg/kg during procedure and 1.25mg/Kg infusion)
Study NCT01555658 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Unfractioned Heparin
Description: Enrolled patients will be randomized in the catheterization laboratory, after the decision to perform PCI by means of planned implantation of stents>33 mm in length in the same coronary vessel, to IV UFH (60 IU/kg intravenous bolus followed by boluses with target activated clotting time 200-250 s)
Study NCT03363971 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Zhi Kang Capsule
Description: 0.3g/capsule, oral, 4 capsules at a time, 3 times a day, half an hour after dinner, warm water delivery; treatment for 6 weeks.
Study NCT03363971 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Simulant agent for Zhi Kang Capsule
Description: 0.3g/capsule,oral, 4 capsules at a time, 3 times a day, half an hour after dinner, warm water delivery; treatment for 6 weeks.
Study NCT03723434 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Single-pulse transcranial magnetic stimulation (spTMS)
Description: Single-pulse TMS (spTMS) will be delivered with a TMS stimulator (MagPro X100 w/ MagOption, MagVenture, Farum, Denmark) and a figure-of-eight TMS coil. 80 spTMS will be repeated at 0.2 Hz. An MRI-based TMS navigation system will be used to navigate the TMS coil (Localite, St Augustin, Germany).
Study NCT03723434 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Single-pulse transcranial magnetic stimulation (spTMS)
Description: Single-pulse TMS (spTMS) will be delivered with a TMS stimulator (MagPro X100 w/ MagOption, MagVenture, Farum, Denmark) and a figure-of-eight TMS coil. 80 spTMS will be repeated at 0.2 Hz. An MRI-based TMS navigation system will be used to navigate the TMS coil (Localite, St Augustin, Germany).
Study NCT03723434 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Paired associative stimulation (PAS)
Description: Paired associative stimulation (PAS) will be applied with two TMS stimulators (MagPro X100 w/ MagOption, MagVenture, Farum, Denmark) and two TMS coils. The pulses from each stimulator/coil will be repeated at 0.2 Hz, duration of run 15 minutes (180 pulses for each stimulator/coil). In different sessions, we will deliver PAS with different asynchrony values to examine their effects on effective connectivity. Coils will be navigated using an MRI-based TMS navigation system (Localite, St Augustin, Germany).
Study NCT03723434 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Paired associative stimulation (PAS)
Description: Paired associative stimulation (PAS) will be applied with two TMS stimulators (MagPro X100 w/ MagOption, MagVenture, Farum, Denmark) and two TMS coils. The pulses from each stimulator/coil will be repeated at 0.2 Hz, duration of run 15 minutes (180 pulses for each stimulator/coil). In different sessions, we will deliver PAS with different asynchrony values to examine their effects on effective connectivity. Coils will be navigated using an MRI-based TMS navigation system (Localite, St Augustin, Germany).
Study NCT03723434 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Repetitive transcranial magnetic stimulation (rTMS)
Description: Repetitive TMS (rTMS) will be applied at 1 and 20 Hz with a TMS stimulator (MagPro X100 w/ MagOption, MagVenture, Farum, Denmark) and a figure-of-eight TMS coil. 300 rTMS pulses will be delivered during 1 and 20 Hz stimulation. An MRI-based TMS navigation system will be used to navigate the TMS coil (Localite, St Augustin, Germany).
Study NCT03538080 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: ACCUVEIN plus ultrasound
Description: Intervention is marking of the saphenous veins with ACCUVEIN system. The AccuVein® AV400 vein illumination system is a laser imaging system that detects superficial veins up to 10 mm deep and digitally displays, through a projected red light, a map of the vascularization on the surface of the skin. in real time, allowing clinicians to check vein permeability and position.~This system is portable and lightweight. It can be easily cleaned, and requires no calibration or adjustment. It does not require any contact with the patient. Second time is completion of marking by ultrasound if necessary
Study NCT03538080 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Ultrasound only
Description: Intervention is marking with ultrasound imaging as in usual practice.
Study NCT02145455 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Unity Total Knee Replacement System
Study NCT02351947 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: upper limb rehabilitation for chronic stroke
Description: subjects in this group will receive upper limb motor learning rehabilitation and undergo fMRI/EEG testing as well as testing of motor function (AMAT and FM).
Study NCT00887484 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BENZOYL PEROXIDE/ CLINDAMYCIN
Description: Commencing at baseline, subjects will apply once daily both treatment arm #1 and treatment arm #2 in a bilateral split-face fashion (allocation to left and right side randomly assigned) for an initial 2 weeks. At 2 weeks, subjects will apply benzoyl peroxide/clindamycin gel to the entire face for an additional 6 weeks.
Study NCT00887484 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: BENZOYL PEROXIDE/ ADAPALENE
Description: Commencing at baseline, subjects will apply once daily both treatment arm #1 and treatment arm #2 in a bilateral split-face fashion (allocation to left and right side randomly assigned) for an initial 2 weeks. At 2 weeks, subjects will apply benzoyl peroxide/clindamycin gel to the entire face for an additional 6 weeks.
Study NCT01061606 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: temsirolimus
Description: Given IV
Study NCT03664115 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Itraconazole 200 mg
Description: itraconazole 200 mg oral tablet daily, on a 21-day cycle.
Study NCT03664115 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Chemotherapy
Description: intravenous doses of cisplatin 80 mg/m2 on day 1 plus gemcitabine 1000 mg/m2 on days 1 and 8 every 3 weeks for a maximum of 6 cycles.~Alternatively, Carboplatin may be used instead of Cisplatin, Carbplatin AUC 5 DAY 1 only Dose = AUC x (GFR + 25) IV in 250 mL Normal Saline over 30 minutes
Study NCT04018638 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: B-FREE
Description: Blood flow-restriction exercise enhancement (B-FREE) will be performed at home 3x/wk for 10 weeks. A blood pressure cuff will be inflated to partially occlude blood to the limb during light weight exercises involving knee extension, body weight squats, and walking.